Related Experiment Video

Updated: Jul 30, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

The overestimation of adherence to pediatric medical regimens

J W Finney1, R J Hook, P C Friman

  • 1Department of Psychology, Virginia Polytechnic Institute, Blacksburg, VA 24061.

Children'S Health Care : Journal of the Association for the Care of Children'S Health
|March 4, 1994
PubMed

Insights

Primary health care providers inaccurately predicted parental adherence to pediatric antibiotic regimens and appointments, overestimating adherence. This highlights the need for better tools to identify nonadherence and ensure appropriate interventions.

Area of Science:

  • Pediatric Health
  • Health Services Research
  • Behavioral Science

Background:

  • Parental adherence to pediatric treatment plans, including antibiotic regimens and follow-up appointments, is crucial for effective healthcare outcomes.
  • Primary health care providers (PHCPs) play a key role in managing pediatric care, yet their ability to predict patient adherence is not well understood.

Purpose of the Study:

  • To evaluate the accuracy of PHCPs' predictions regarding parental adherence to children's short-term antibiotic prescriptions.
  • To assess the accuracy of PHCPs' predictions of parental adherence to scheduled pediatric follow-up appointments.
  • To compare PHCP adherence predictions with objective adherence measures.

Main Methods:

  • PHCPs' predictions of parental adherence were collected.
  • Objective measures were used to quantify actual parental adherence to antibiotic regimens and follow-up appointments.
  • A comparative analysis was performed between predicted and objectively measured adherence rates.

Main Results:

  • PHCPs were found to be poor predictors of nonadherence, consistently overestimating the percentage of parents who would adhere to treatment.
  • The study identified a significant discrepancy between perceived and actual adherence rates.
  • Overestimation of adherence by providers may lead to under-intervention for nonadherent pediatric patients.

Conclusions:

  • Accurate identification of nonadherence is essential for implementing targeted adherence improvement strategies in pediatric care.
  • The findings underscore the need for developing and utilizing robust behavioral predictors to improve the identification of nonadherent patients.
  • More accurate adherence prediction can optimize the application of interventions, ensuring that nonadherent patients receive necessary support.

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Concept Videos

Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...